Fidelity Investments
BEAM icon

Fidelity Investments’s Beam Therapeutics BEAM Stock Holding History

Fidelity Investments’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$316M Buy
12,926,476
+317,474
+3% +$8.84M 0.01% 720
2026
Q2 		$433M Buy
12,609,002
+156,803
+1% +$4.73M 0.02% 608
2026
Q1 		$297M Buy
12,452,199
+543,061
+5% +$15.1M 0.02% 693
2025
Q4 		$330M Buy
11,909,138
+216,285
+2% +$5.52M 0.02% 664
2025
Q3 		$284M Sell
11,692,853
-1,268,606
-10% -$25.2M 0.01% 709
2025
Q2 		$220M Buy
12,961,459
+5,041,406
+64% +$87.8M 0.01% 777
2025
Q1 		$155M Buy
7,920,053
+4,602,759
+139% +$121M 0.01% 915
2024
Q4 		$82.3M Sell
3,317,294
-894,223
-21% -$22.8M ﹤0.01% 1191
2024
Q3 		$103M Sell
4,211,517
-196,178
-4% -$5.07M 0.01% 1087
2024
Q2 		$103M Sell
4,407,695
-486,758
-10% -$12M 0.01% 1027
2024
Q1 		$162M Sell
4,894,453
-1,285,869
-21% -$40.1M 0.01% 872
2023
Q4 		$168M Sell
6,180,322
-317,509
-5% -$7.89M 0.01% 817
2023
Q3 		$156M Sell
6,497,831
-639,878
-9% -$17.2M 0.01% 798
2023
Q2 		$228M Buy
7,137,709
+1,050,156
+17% +$34.1M 0.02% 671
2023
Q1 		$186M Buy
6,087,553
+1,121,564
+23% +$44.3M 0.02% 737
2022
Q4 		$194M Buy
4,965,989
+381,854
+8% +$17.1M 0.02% 696
2022
Q3 		$218M Sell
4,584,135
-215,964
-4% -$12.3M 0.02% 628
2022
Q2 		$186M Sell
4,800,099
-614,997
-11% -$24.4M 0.02% 718
2022
Q1 		$310M Buy
5,415,096
+1,493,793
+38% +$98M 0.02% 620
2021
Q4 		$312M Sell
3,921,303
-2,863
-0.1% -$245K 0.02% 629
2021
Q3 		$341M Sell
3,924,166
-3,761,094
-49% -$378M 0.03% 575
2021
Q2 		$989M Buy
7,685,260
+1
+0% +$80 0.08% 231
2021
Q1 		$615M Buy
7,685,259
+356,673
+5% +$33.9M 0.05% 361
2020
Q4 		$598M Hold
7,328,586
– – 0.05% 351
2020
Q3 		$180M Buy
7,328,586
+356,674
+5% +$8.85M 0.02% 667
2020
Q2 		$195M Hold
6,971,912
– – 0.02% 622
2020
Q1 		$125M Buy
+6,971,912
New +$152M 0.02% 678

Other funds holding BEAM

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $17.4B AUM 41.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $8.04B AUM 33.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Fidelity Investments's BEAM Position: Q3 2026 in Review

Fidelity Investments increased its Beam Therapeutics (BEAM) stake by 2.5% in Q3 2026, buying an estimated $8.84M and bringing the position to 12,926,476 shares worth $316M. The position accounts for 0.01% of the portfolio, ranked #720.

Fidelity Investments first reported a position in BEAM in Q1 2020 and has held it in 27 quarters since. The position peaked at $989M in Q2 2021. 191 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Fidelity Investments held 12,926,476 shares of Beam Therapeutics worth $316M as of Q3 2026.
  • Fidelity Investments bought 317,474 Beam Therapeutics shares in Q3 2026, an estimated $8.84M.
  • Beam Therapeutics made up 0.01% of Fidelity Investments's portfolio in Q3 2026, its #720 holding.
  • Fidelity Investments first reported a position in Beam Therapeutics in Q1 2020 and has held it in 27 quarters since.
  • Fidelity Investments's Beam Therapeutics position peaked at $989M in Q2 2021.
  • 191 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.